Subtopic Deep Dive
Hypertensive Disorders of Pregnancy
Research Guide
What is Hypertensive Disorders of Pregnancy?
Hypertensive Disorders of Pregnancy encompass gestational hypertension, preeclampsia, and eclampsia, characterized by new-onset hypertension after 20 weeks gestation with or without proteinuria and organ dysfunction.
These disorders affect 2-8% of pregnancies worldwide and rank among leading causes of maternal and perinatal mortality (Gestational Hypertension and Preeclampsia, 2020, 2364 citations). Classification follows ACOG guidelines distinguishing gestational hypertension from preeclampsia based on proteinuria thresholds and severe features (ACOG Committee on Obstetric Practice, 2002, 1053 citations). Management includes antihypertensive therapy, aspirin prophylaxis, and timed delivery.
Why It Matters
Standardized diagnosis and management reduce maternal mortality by 17.6% in the US from hypertensive diseases (ACOG Committee on Obstetric Practice, 2002). Low-dose aspirin lowers preterm preeclampsia incidence in high-risk women (Rolnik et al., 2017, 2069 citations). Long-term surveillance identifies cardiovascular risks post-preeclampsia, with Bellamy et al. (2007, 2474 citations) showing doubled heart disease risk later in life. The sFlt-1:PlGF ratio predicts short-term preeclampsia absence, aiding triage (Zeisler et al., 2016, 1623 citations).
Key Research Challenges
Heterogeneous Diagnostic Criteria
Confusion persists in terminology and classification across guidelines, complicating uniform diagnosis (ACOG Committee on Obstetric Practice, 2002). Proteinuria thresholds vary, affecting preeclampsia identification. International harmonization remains unresolved.
Risk Stratification Accuracy
Antenatal risk factors like maternal age and BMI predict preeclampsia but lack precision for individualized surveillance (Duckitt and Harrington, 2005, 1770 citations). First-trimester screening models improve but require validation (Poon et al., 2019, 1068 citations). False positives burden low-risk pregnancies.
Long-term Cardiovascular Prediction
Preeclampsia elevates future cardiovascular disease risk, yet mechanistic links and surveillance protocols need refinement (Bellamy et al., 2007; Wu et al., 2017, 991 citations). Shared endothelial dysfunction hypotheses require longitudinal trials. Optimal postpartum interventions are undefined.
Essential Papers
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
Leanne Bellamy, Juan-Pablo Casas, Aroon D. Hingorani et al. · 2007 · BMJ · 2.5K citations
A history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in women. This association might reflect a common cause for pre-eclampsia and cardiovascular disease, ...
Gestational Hypertension and Preeclampsia
· 2020 · Obstetrics and Gynecology · 2.4K citations
Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2–8% of pregnancies globa...
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik, D. Wright, Liona C. Poon et al. · 2017 · New England Journal of Medicine · 2.1K citations
Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program ...
Preeclampsia
Sarosh Rana, Elizabeth Lemoine, Joey P. Granger et al. · 2019 · Circulation Research · 1.9K citations
Hypertensive disorders of pregnancy—chronic hypertension, gestational hypertension, and preeclampsia—are uniquely challenging as the pathology and its therapeutic management simultaneously affect m...
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
Kirsten Duckitt, Deborah J. Harrington · 2005 · BMJ · 1.8K citations
These factors and the underlying evidence base can be used to assess risk at booking so that a suitable surveillance routine to detect pre-eclampsia can be planned for the rest of the pregnancy.
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Harald Zeisler, Elisa Llurba, Frédéric Chantraine et al. · 2016 · New England Journal of Medicine · 1.6K citations
An sFlt-1:PlGF ratio of 38 or lower can be used to predict the short-term absence of preeclampsia in women in whom the syndrome is suspected clinically. (Funded by Roche Diagnostics.).
Pre-eclampsia: pathophysiology and clinical implications
Graham J. Burton, Christopher W.G. Redman, James M. Roberts et al. · 2019 · BMJ · 1.1K citations
Abstract Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical presentation is highly variable but hypertension and proteinuria are usually seen. These system...
Reading Guide
Foundational Papers
Start with ACOG Committee (2002, 1053 citations) for diagnosis standards; Duckitt and Harrington (2005, 1770 citations) for risk factors; Bellamy et al. (2007, 2474 citations) for cardiovascular sequelae establishing core classification and epidemiology.
Recent Advances
Study Rolnik et al. (2017, 2069 citations) for aspirin prevention; Zeisler et al. (2016, 1623 citations) for biomarker prediction; Poon et al. (2019, 1068 citations) for FIGO screening guidelines.
Core Methods
Core techniques include sFlt-1:PlGF ratio testing (Zeisler et al., 2016), first-trimester risk calculators (Poon et al., 2019), low-dose aspirin prophylaxis (Rolnik et al., 2017), and meta-analyses of cohort data (Bellamy et al., 2007).
How PapersFlow Helps You Research Hypertensive Disorders of Pregnancy
Discover & Search
Research Agent uses searchPapers and exaSearch to query 'sFlt-1:PlGF ratio preeclampsia prediction' retrieving Zeisler et al. (2016, 1623 citations) as top hit. citationGraph reveals forward citations linking to Poon et al. (2019) FIGO guidelines. findSimilarPapers expands to Rolnik et al. (2017) aspirin trials.
Analyze & Verify
Analysis Agent applies readPaperContent to extract sFlt-1:PlGF thresholds from Zeisler et al. (2016), then verifyResponse with CoVe cross-checks against Bellamy et al. (2007) meta-analysis. runPythonAnalysis imports citation data via pandas to plot risk ratios (NumPy visualization). GRADE grading scores aspirin prophylaxis evidence as high-quality from Rolnik et al. (2017).
Synthesize & Write
Synthesis Agent detects gaps in long-term surveillance post-preeclampsia via contradiction flagging between Duckitt (2005) risk factors and Wu et al. (2017) outcomes. Writing Agent uses latexEditText to draft management protocols, latexSyncCitations for ACOG (2002) integration, and latexCompile for guideline tables. exportMermaid generates etiology flowcharts from Burton et al. (2019).
Use Cases
"Meta-analyze preeclampsia cardiovascular risk ratios from top papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of Bellamy 2007 and Wu 2017 risk ratios) → matplotlib forest plot output.
"Draft LaTeX systematic review on aspirin prophylaxis for preeclampsia"
Synthesis Agent → gap detection on Rolnik 2017 → Writing Agent → latexEditText (protocol draft) → latexSyncCitations (Poon 2019) → latexCompile (PDF review with tables).
"Find analysis code for sFlt-1:PlGF ratio models"
Research Agent → paperExtractUrls (Zeisler 2016) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis (replicate ratio calculations with shared NumPy script).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ papers on hypertensive disorders, chaining searchPapers → citationGraph → GRADE grading for ACOG-aligned management evidence. DeepScan applies 7-step analysis with CoVe checkpoints to verify aspirin trial outcomes from Rolnik et al. (2017). Theorizer generates hypotheses on preeclampsia-cardiovascular links from Bellamy et al. (2007) and Rana et al. (2019).
Frequently Asked Questions
What defines hypertensive disorders of pregnancy?
New-onset hypertension after 20 weeks gestation, including gestational hypertension (BP ≥140/90 without proteinuria), preeclampsia (with proteinuria or organ dysfunction), and eclampsia (with seizures) per ACOG guidelines (ACOG Committee on Obstetric Practice, 2002).
What are key methods for preeclampsia prediction?
First-trimester screening combines maternal factors, mean arterial pressure, and biomarkers like PlGF (Poon et al., 2019). sFlt-1:PlGF ratio below 38 rules out short-term preeclampsia (Zeisler et al., 2016). Low-dose aspirin prophylaxis targets high-risk cases (Rolnik et al., 2017).
Which papers have most citations on this topic?
Bellamy et al. (2007, 2474 citations) on cardiovascular risks; Gestational Hypertension and Preeclampsia (2020, 2364 citations) on global epidemiology; Rolnik et al. (2017, 2069 citations) on aspirin efficacy.
What open problems exist?
Unresolved challenges include unifying diagnostic criteria internationally, refining long-term cardiovascular surveillance, and identifying preeclampsia's placental origins (Burton et al., 2019). Postpartum risk mitigation lacks randomized trials.
Research Pregnancy and preeclampsia studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hypertensive Disorders of Pregnancy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers